Comparing Web-Based Platforms for Promoting HIV Self-Testing and Pre-Exposure Prophylaxis Uptake in High-Risk Men Who Have Sex With Men: Protocol for a Longitudinal Cohort Study.

HIV HIV self-testing dating apps informational search websites men who have sex with men online advertising social media web-based platforms

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
19 Oct 2020
Historique:
received: 18 05 2020
accepted: 11 08 2020
revised: 06 08 2020
entrez: 19 10 2020
pubmed: 20 10 2020
medline: 20 10 2020
Statut: epublish

Résumé

The majority of those living with HIV in the United States are men who have sex with men (MSM), and young, minority MSM account for more new HIV infections than any other group. HIV transmission can be reduced through detection and early treatment initiation or by starting pre-exposure prophylaxis (PrEP), but rates of testing are lower than recommended among MSM, and PrEP uptake has been slow. Although promoting HIV testing and PrEP uptake by placing advertisements on web-based platforms - such as social media websites and dating apps - is a promising approach for promoting HIV testing and PrEP, the relative effectiveness of HIV prevention advertising on common web-based platforms is underexamined. This study aims to evaluate the relative effectiveness of advertisements placed on 3 types of web-based platforms (social media websites, dating apps, and informational websites) for promoting HIV self-testing and PrEP uptake. Advertisements will be placed on social media websites (Facebook, Instagram, and Twitter), dating apps (Grindr, Jack'd, and Hornet), and informational search websites (Google, Yahoo, and Bing) to recruit approximately 400 young (18-30 years old), minority (Black or Latino) MSM at elevated risk of HIV exposure. Recruitment will occur in 3 waves, with each wave running advertisements on 1 website from each type of platform. The number of participants per platform is not prespecified, and recruitment in each wave will occur until approximately 133 HIV self-tests are ordered. Participants will complete a baseline survey assessing risk behavior, substance use, psychological readiness to test, and attitudes and then receive an electronic code to order a free home-based HIV self-test kit. Two follow-ups are planned to assess HIV self-test results and PrEP uptake. Recruitment was completed in July 2020. Findings may improve our understanding of how the platform users' receptivity to test for HIV differs across web-based platforms and thus may assist in facilitating web-based HIV prevention campaigns. ClinicalTrials.gov NCT04155502; https://clinicaltrials.gov/ct2/show/NCT04155502. DERR1-10.2196/20417.

Sections du résumé

BACKGROUND BACKGROUND
The majority of those living with HIV in the United States are men who have sex with men (MSM), and young, minority MSM account for more new HIV infections than any other group. HIV transmission can be reduced through detection and early treatment initiation or by starting pre-exposure prophylaxis (PrEP), but rates of testing are lower than recommended among MSM, and PrEP uptake has been slow. Although promoting HIV testing and PrEP uptake by placing advertisements on web-based platforms - such as social media websites and dating apps - is a promising approach for promoting HIV testing and PrEP, the relative effectiveness of HIV prevention advertising on common web-based platforms is underexamined.
OBJECTIVE OBJECTIVE
This study aims to evaluate the relative effectiveness of advertisements placed on 3 types of web-based platforms (social media websites, dating apps, and informational websites) for promoting HIV self-testing and PrEP uptake.
METHODS METHODS
Advertisements will be placed on social media websites (Facebook, Instagram, and Twitter), dating apps (Grindr, Jack'd, and Hornet), and informational search websites (Google, Yahoo, and Bing) to recruit approximately 400 young (18-30 years old), minority (Black or Latino) MSM at elevated risk of HIV exposure. Recruitment will occur in 3 waves, with each wave running advertisements on 1 website from each type of platform. The number of participants per platform is not prespecified, and recruitment in each wave will occur until approximately 133 HIV self-tests are ordered. Participants will complete a baseline survey assessing risk behavior, substance use, psychological readiness to test, and attitudes and then receive an electronic code to order a free home-based HIV self-test kit. Two follow-ups are planned to assess HIV self-test results and PrEP uptake.
RESULTS RESULTS
Recruitment was completed in July 2020.
CONCLUSIONS CONCLUSIONS
Findings may improve our understanding of how the platform users' receptivity to test for HIV differs across web-based platforms and thus may assist in facilitating web-based HIV prevention campaigns.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT04155502; https://clinicaltrials.gov/ct2/show/NCT04155502.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/20417.

Identifiants

pubmed: 33074164
pii: v9i10e20417
doi: 10.2196/20417
pmc: PMC7605984
doi:

Banques de données

ClinicalTrials.gov
['NCT04155502']

Types de publication

Journal Article

Langues

eng

Pagination

e20417

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA029926
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA037202
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA040309
Pays : United States

Informations de copyright

©Shea M Lemley, Jeffrey D Klausner, Sean D Young, Chrysovalantis Stafylis, Caroline Mulatya, Neal Oden, Haiyi Xie, Leslie Revoredo, Dikla Shmueli-Blumberg, Emily Hichborn, Erin McKelle, Landhing Moran, Petra Jacobs, Lisa A Marsch. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 19.10.2020.

Références

JMIR Public Health Surveill. 2016 May 17;2(1):e22
pubmed: 27244769
J Homosex. 2016;63(2):278-99
pubmed: 26295497
Ann Intern Med. 2016 Nov 15;165(10):690-699
pubmed: 27595276
Sex Transm Infect. 2017 Feb;93(1):52-55
pubmed: 27356041
AIDS. 2004 Jan 23;18(2):303-9
pubmed: 15075549
AIDS Educ Prev. 2016 Aug;28(4):341-50
pubmed: 27427928
Sex Transm Infect. 2003 Dec;79(6):442-7
pubmed: 14663117
Epidemiology. 2018 Jul;29(4):574-578
pubmed: 29864105
Health Educ Res. 2019 Feb 1;34(1):15-26
pubmed: 30508106
J Ethn Subst Abuse. 2014;13(4):430-47
pubmed: 25397640
AIDS Behav. 2013 Jan;17(1):340-9
pubmed: 22038078
AIDS Behav. 2012 Jan;16(1):23-9
pubmed: 21279431
AIDS Behav. 2005 Dec;9(4):513-23
pubmed: 16328712
Drug Alcohol Depend. 2017 May 1;174:106-112
pubmed: 28319751
AIDS Educ Prev. 2008 Oct;20(5):408-19
pubmed: 18956982
AIDS Behav. 2011 Apr;15(3):613-20
pubmed: 20652629
J Racial Ethn Health Disparities. 2015 Mar;2(1):1-10
pubmed: 25960944
LGBT Health. 2015 Sep;2(3):200-20
pubmed: 26788669
Public Health Rep. 2007;122 Suppl 1:56-62
pubmed: 17354528
Clin Infect Dis. 2015 Nov 15;61(10):1601-3
pubmed: 26334052
AIDS Behav. 2014 Sep;18(9):1625-9
pubmed: 24062015
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
Health Serv Res. 2009 Dec;44(6):2093-105
pubmed: 19732170
AIDS Patient Care STDS. 2013 Apr;27(4):248-54
pubmed: 23565928
J Community Health. 2013 Feb;38(1):62-9
pubmed: 22752575
Am J Public Health. 2012 May;102 Suppl 2:S242-9
pubmed: 22401516
Curr Opin Psychol. 2016 May;9:38-43
pubmed: 26726313
Clin Infect Dis. 2016 Jun 1;62(11):1450-3
pubmed: 26980878
Health Educ Q. 1994 Winter;21(4):471-86
pubmed: 7843978
Sex Health. 2016 May 23;:
pubmed: 27209076
Drug Alcohol Depend. 2012 Jun 1;123(1-3):15-21
pubmed: 22055012
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150
pubmed: 30335734
Sex Transm Infect. 2017 Aug;93(5):342-346
pubmed: 28400466
AIDS Behav. 2017 Feb;21(2):561-575
pubmed: 27498198
Sex Transm Dis. 2011 May;38(5):419-28
pubmed: 21183863
Lancet HIV. 2015 Jan;2(1):e27-32
pubmed: 26236767
J Adolesc Health. 2012 Mar;50(3):296-303
pubmed: 22325136
Subst Use Misuse. 2016 Nov 9;51(13):1751-9
pubmed: 27556866
Am J Public Health. 2006 Jun;96(6):1007-19
pubmed: 16670223
J Urban Health. 2016 Apr;93(2):388-99
pubmed: 26936854
AIDS Behav. 2015 Jun;19 Suppl 2:112-22
pubmed: 25572832
Curr HIV Res. 2018;16(3):237-249
pubmed: 30062970
Subst Use Misuse. 2007;42(10):1613-28
pubmed: 17918031
PLoS One. 2018 Jul 12;13(7):e0199527
pubmed: 30001360
AIDS Patient Care STDS. 2015 Aug;29(8):423-9
pubmed: 26083143

Auteurs

Shea M Lemley (SM)

Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.

Jeffrey D Klausner (JD)

David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Sean D Young (SD)

Department of Emergency Medicine, School of Medicine, University of California, Irvine, Irvine, CA, United States.
Department of Informatics, Bren School of Information and Computer Sciences, University of California, Irvine, Irvine, CA, United States.

Chrysovalantis Stafylis (C)

David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Caroline Mulatya (C)

The Emmes Company, LLC, Rockville, MD, United States.

Neal Oden (N)

The Emmes Company, LLC, Rockville, MD, United States.

Haiyi Xie (H)

Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.

Leslie Revoredo (L)

The Emmes Company, LLC, Rockville, MD, United States.

Dikla Shmueli-Blumberg (D)

The Emmes Company, LLC, Rockville, MD, United States.

Emily Hichborn (E)

Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.

Erin McKelle (E)

ETR Associates (Education, Training and Research), Oakland, CA, United States.

Landhing Moran (L)

National Institute on Drug Abuse, Bethesda, MD, United States.

Petra Jacobs (P)

National Institute on Drug Abuse, Bethesda, MD, United States.

Lisa A Marsch (LA)

Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.

Classifications MeSH